Cepharanthine Suppresses Herpes Simplex Virus Type 1 Replication Through the Downregulation of the PI3K/Akt and p38 MAPK Signaling Pathways

December 2021 in “ Frontiers in Microbiology ”

Yao Liu, Li Chen, Wenjun Liu, Dan Li, Jiuseng Zeng, Qiong Tang, Yuexin Zhang, Fei Luan, Nan Zeng

We don't know much about this study yet.

We're maintaining the world's largest resposity of hair loss research. You can help out the community by sending a PDF of this study here . Not sure how to get a study's PDF? You can email the authors of the study.

View this study on frontiersin.org →

Discuss this study in the Community →

Research cited in this study

2 / 2 results

research Cepharanthine: A Review of the Antiviral Potential of a Japanese-Approved Alopecia Drug in COVID-19

70 citations , July 2020 in “Pharmacological Reports”

Cepharanthine, a Japanese hair loss drug, shows promise as a COVID-19 treatment but needs more testing.

research Cepharanthine: An Update of Its Mode of Action, Pharmacological Properties, and Medical Applications

125 citations , May 2019 in “Phytomedicine”

Cepharanthine is a well-tolerated drug with multiple medical uses, including anti-inflammatory and anti-cancer properties.